Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS Database Analysis
Background: Thymic carcinoma is a rare and highly malignant tumor with a dismal prognosis, which occasionally coexists with myasthenia gravis (MG). This study aims to investigate the MG incidence on a surgical cohort of patients with thymic carcinoma and to explore its influence on long-term surviva...
Elmentve itt :
Szerzők: | |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2022
|
Sorozat: | DIAGNOSTICS
12 No. 7 |
Tárgyszavak: | |
doi: | 10.3390/diagnostics12071764 |
mtmt: | 33131894 |
Online Access: | http://publicatio.bibl.u-szeged.hu/25338 |
LEADER | 02884nab a2200397 i 4500 | ||
---|---|---|---|
001 | publ25338 | ||
005 | 20221019084111.0 | ||
008 | 221019s2022 hu o 0|| Angol d | ||
022 | |a 2075-4418 | ||
024 | 7 | |a 10.3390/diagnostics12071764 |2 doi | |
024 | 7 | |a 33131894 |2 mtmt | |
040 | |a SZTE Publicatio Repozitórium |b hun | ||
041 | |a Angol | ||
100 | 1 | |a Lococo Filippo | |
245 | 1 | 0 | |a Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS Database Analysis |h [elektronikus dokumentum] / |c Lococo Filippo |
260 | |c 2022 | ||
300 | |a 11 | ||
490 | 0 | |a DIAGNOSTICS |v 12 No. 7 | |
520 | 3 | |a Background: Thymic carcinoma is a rare and highly malignant tumor with a dismal prognosis, which occasionally coexists with myasthenia gravis (MG). This study aims to investigate the MG incidence on a surgical cohort of patients with thymic carcinoma and to explore its influence on long-term survival. Methods: the prospectively collected data from the ESTS database on thymic epithelial tumors were reviewed. Clinical, pathological, and survival information on thymic carcinoma were analyzed. Results: the analysis was conducted on 203 patients, with an equal gender distribution (96 males and 107 females). MG was detected in 22 (10.8%) patients, more frequently elderly (>60 years, p = 0.048) and male (p = 0.003). Induction therapy was performed in 22 (10.8%) cases. After surgery, 120 (59.1%) patients had a Masaoka stage II-III while complete resection (R0) was achieved in 158 (77.8%). Adjuvant therapy was performed in 68 cases. Mean follow-up was 60 (SD = 14) months. The 3-year, 5-year and 10-year survival rates were 79%, 75% and 63%, respectively. MG did not seem to influence long-term survival (5-year survival in non-MG-TCs 78% vs. 50% in MG-TCs, p = ns) as age < 60 years, female gender, early Masaoka stage, and postoperative radiotherapy did, conversely. Conclusions: myasthenia occurred in about 10% of thymic carcinomas and it did not seem to affect significantly the long-term prognosis in surgically treated thymic carcinoma-patients. | |
650 | 4 | |a Klinikai orvostan | |
700 | 0 | 1 | |a Nachira Dania |e aut |
700 | 0 | 1 | |a Chiappetta Marco |e aut |
700 | 0 | 1 | |a Evangelista Jessica |e aut |
700 | 0 | 1 | |a Falcoz Pierre Emmanuel |e aut |
700 | 0 | 1 | |a Ruffini Enrico |e aut |
700 | 0 | 2 | |a Van Schil Paul |e aut |
700 | 0 | 2 | |a Scarci Marco |e aut |
700 | 0 | 2 | |a Furák József |e aut |
700 | 0 | 2 | |a Sollitto Francesco |e aut |
700 | 0 | 2 | |a Guerrera Francesco |e aut |
700 | 0 | 2 | |a Spaggiari Lorenzo |e aut |
700 | 0 | 2 | |a Aigner Clemens |e aut |
700 | 0 | 2 | |a Evangelia Liverakou |e aut |
700 | 0 | 2 | |a Billè Andrea |e aut |
700 | 0 | 2 | |a Kollaborációs szervezet: ESTS Thymic Working Group |e aut |
856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/25338/1/FilippoLococFurak.....DoesMyastheniaGravisAffectLong-TermSurvivalinThymicCarcinomas_AnESTSDatabaseAnalysis.pdf |z Dokumentum-elérés |